Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wireless 2000 RF & UWB Technologies Ltd. was a Canadian medical technology company that focused on developing non-invasive diagnostic tools using Ultra-Wideband (UWB) radar. The company's primary innovation was the PneumoScan, a portable, handheld device designed to detect and monitor fluid in the lungs, such as pleural effusion and pulmonary edema, without the need for ionizing radiation. This technology aimed to provide rapid, point-of-care diagnostics for conditions like congestive heart failure and pneumonia in both clinical and home environments. Beyond lung diagnostics, the company explored UWB applications for non-contact vital sign monitoring and brain imaging. Despite the technical promise of its UWB platform and receiving FDA clearance for its flagship product, the company is currently inactive.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wireless 2000.